Overview

Tofacitinib Bioequivalence Study Comparing Tablets And Capsules

Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The overall aim of the study is to establish bioequivalence between commercial tofacitinib tablet formulations with the tofacitinib capsule formulation.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Tofacitinib